Ancestral SARS-CoV-2, but not Omicron, replicates less efficiently in primary pediatric nasal epithelial cells

Yanshan Zhu1, Keng Yih Chew1, Melanie Wu1

  • 1School of Chemistry and Molecular Biosciences, The University of Queensland, Brisbane, Queensland, Australia.

Plos Biology
|August 1, 2022
PubMed

Insights

Children

Area of Science:

  • Virology
  • Pediatric Infectious Diseases
  • Immunology

Background:

  • Children generally exhibit milder Coronavirus Disease 2019 (COVID-19) symptoms and lower susceptibility to SARS-CoV-2 infection compared to adults.
  • Emergence of SARS-CoV-2 variants of concern (VOCs) correlates with increased pediatric infections, prompting investigation into underlying causes.

Purpose of the Study:

  • To investigate differences in SARS-CoV-2 replication and antiviral responses in pediatric versus adult nasal epithelial cells (NECs).
  • To compare the susceptibility of pediatric NECs to ancestral SARS-CoV-2 and its VOCs, including Delta and Omicron variants.

Main Methods:

  • Primary nasal epithelial cells (NECs) from children and adults were differentiated at an air-liquid interface.
  • These NECs were infected with ancestral SARS-CoV-2, Delta, and Omicron variants to assess viral replication and host antiviral responses.

Main Results:

  • Ancestral SARS-CoV-2 replicated to significantly lower titers in pediatric NECs compared to adult NECs, associated with a heightened antiviral response.
  • The Delta variant also showed reduced replication in pediatric NECs, whereas Omicron replicated more efficiently in pediatric NECs than Delta or the ancestral strain.
  • Omicron variant demonstrated higher viral RNA levels in pediatric NECs compared to Delta and ancestral SARS-CoV-2.

Conclusions:

  • Pediatric nasal epithelium inherently supports lower replication of ancestral SARS-CoV-2, linked to a robust antiviral defense.
  • The evolving SARS-CoV-2 landscape, particularly with variants like Omicron, may alter this differential susceptibility in children's nasal passages.

Related Concept Videos

Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
Coronavirus01:29

Coronavirus

Coronaviruses, including the severe acute respiratory syndrome coronavirus (SARS-CoV), are enveloped viruses characterized by their single-stranded, positive-sense RNA genome and helical nucleocapsid structure. The hallmark of these viruses is their club-shaped spike (S) glycoproteins that protrude from the viral envelope, facilitating attachment to host cells. Typically, coronaviruses infect the upper respiratory tract, often causing mild or asymptomatic disease. However, certain strains like...
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...